ArticleCurrent oncology (Toronto, Ont.)2024

Real-World Oncological Outcomes of Nivolumab Plus Ipilimumab in Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study in Japan.

Tomoki Taniguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.